Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -42% | 32.4% | -88.1% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -51.4% | -60.9% | -27% | 49.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,232.9% | -1,368.1% | -583.9% | -30.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,406.9% | -4,015.2% | -1,060.7% | -91.8% |
| EPS Diluted | -3.87 | -10.19 | -18.5 | -17.4 |
| % Growth | 62% | 44.9% | -6.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |